Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7084119rdf:typepubmed:Citationlld:pubmed
pubmed-article:7084119lifeskim:mentionsumls-concept:C0007603lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1705480lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1882726lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C0439851lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1948023lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1623073lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1883712lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1552596lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:7084119lifeskim:mentionsumls-concept:C1947931lld:lifeskim
pubmed-article:7084119pubmed:issue1lld:pubmed
pubmed-article:7084119pubmed:dateCreated1982-8-14lld:pubmed
pubmed-article:7084119pubmed:abstractTextRat liver plasma membranes were incubated in Ca2+-free buffer plus 0.5 mM ethyleneglycol-bis(beta-aminoethyl ether)-N,N'-tetraacetic acid (EGTA) containing 0.5 mg/ml deoxycholate or 50 mU/ml vasopressin or both compounds. The membrane phospholipids were extracted, separated by two-dimensional chromatography and quantitated by phosphorus analysis. Vasopressin significantly enhanced degradation of phosphatidylinositol in the presence of deoxycholate (21% with deoxycholate alone versus 32% in the presence of vasopressin plus deoxycholate). However, no significant effects of deoxycholate or vasopressin were seen on the degradation of phosphatidylcholine, phosphatidylethanolamine or phosphatidylserine. These results indicate that specific degradation of phosphatidylinositol can be seen after direct addition of vasopressin to a plasma membrane preparation.lld:pubmed
pubmed-article:7084119pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7084119pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7084119pubmed:languageenglld:pubmed
pubmed-article:7084119pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7084119pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7084119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7084119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7084119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7084119pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7084119pubmed:statusMEDLINElld:pubmed
pubmed-article:7084119pubmed:monthJullld:pubmed
pubmed-article:7084119pubmed:issn0013-7227lld:pubmed
pubmed-article:7084119pubmed:authorpubmed-author:FainJ NJNlld:pubmed
pubmed-article:7084119pubmed:authorpubmed-author:WallaceM AMAlld:pubmed
pubmed-article:7084119pubmed:authorpubmed-author:LiS YSYlld:pubmed
pubmed-article:7084119pubmed:authorpubmed-author:RandazzoPPlld:pubmed
pubmed-article:7084119pubmed:issnTypePrintlld:pubmed
pubmed-article:7084119pubmed:volume111lld:pubmed
pubmed-article:7084119pubmed:ownerNLMlld:pubmed
pubmed-article:7084119pubmed:authorsCompleteYlld:pubmed
pubmed-article:7084119pubmed:pagination341-3lld:pubmed
pubmed-article:7084119pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:meshHeadingpubmed-meshheading:7084119-...lld:pubmed
pubmed-article:7084119pubmed:year1982lld:pubmed
pubmed-article:7084119pubmed:articleTitleDirect stimulation of phosphatidylinositol degradation by addition of vasopressin to purified rat liver plasma membranes.lld:pubmed
pubmed-article:7084119pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7084119pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed